Non-Whites Sorely Underrepresented in Phase 3 Psoriasis Trials Non-Whites Sorely Underrepresented in Phase 3 Psoriasis Trials

Participation by non-White patients in phase 3 therapeutic trials for plaque psoriasis is less than 15%.Medscape Medical News

Source: Medscape Dermatology Headlines - October 21, 2020 Category: Dermatology Tags: Dermatology News Source Type: news